Comparing Afinitor vs Everolimus
| Afinitor | Everolimus |
|
|---|
| Afinitor (everolimus) | Everolimus |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Afinitor (everolimus) is a targeted medicine that may be used to treat various cancers and TSC-associated conditions. It reduces the blood supply to the cancers which slows down their growth and... View more |
Prescription only
Prescribed for Neuroendocrine Carcinoma, Breast Cancer, Organ Transplant - Rejection Prophylaxis, Renal Angiomyolipoma, Pancreatic Cancer, Renal Cell Carcinoma, Subependymal Giant Cell Astrocytoma... View more |
Related suggestions Breast Cancer
Pancreatic Cancer
Neuroendocrine Carcinoma
|
|||||||||||||||
| More about Afinitor (everolimus) | More about Everolimus | ||||||||||||||||
| Generic Status | |||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Afinitor has an average rating of 5.6 out of 10 from a total of 19 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 39% reported a negative effect. |
Everolimus has an average rating of 5.9 out of 10 from a total of 26 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Afinitor side effects in more detail. |
Commonly reported side effects include:
See also: everolimus side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Afinitor prices and generic prices |
View all everolimus prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other everolimus brands include: Afinitor Disperz, Zortress | Afinitor, Afinitor Disperz, Zortress | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
35 hours |
35 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 466 drugs are known to interact with Afinitor:
|
A total of 466 drugs are known to interact with everolimus:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 30, 2009 |
March 30, 2009 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.